Cita APA

Hashimoto, A., Oikawa, T., Hashimoto, S., Sugino, H., Yoshikawa, A., Otsuka, Y., . . . Sabe, H. (2016). P53- and mevalonate pathway–driven malignancies require Arf6 for metastasis and drug resistance. J Cell Biol.

Chicago Style Citation

Hashimoto, Ari, et al. "P53- and Mevalonate Pathway–driven Malignancies Require Arf6 for Metastasis and Drug Resistance." J Cell Biol 2016.

Cita MLA

Hashimoto, Ari, et al. "P53- and Mevalonate Pathway–driven Malignancies Require Arf6 for Metastasis and Drug Resistance." J Cell Biol 2016.